AAN: Prophylactic Zonisamide Effective in Pediatric Migraine
By Elana Gotkine HealthDay Reporter
MONDAY, March 3, 2025 -- For pediatric patients with migraine, prophylactic zonisamide use can significantly reduce the median number of headache days per month (HDPM), according to a study scheduled for presentation at the annual meeting of the American Academy of Neurology, to be held from April 5 to 9 in San Diego.
Isabelle Kang, from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined zonisamide prophylaxis and reduction in HDPM in pediatric patients with migraine in a retrospective cohort study conducted at a single institution. A total of 256 patients (70 percent female) were included in the study, with a median age of 15 years.
The researchers found that 28 percent of the patients had intractable migraine (had failed two or more prophylactic medications). At first follow-up after zonisamide initiation, there was a median decrease from 16 to six HDPM for the entire cohort. The group that followed up within two to six months demonstrated the largest reduction, with a median decrease of six HDPM. At first follow-up, there was a significant median decrease of six HDPM seen in both intractable and nonintractable groups.
"Migraine disease is debilitating and can lead to kids having to miss school and other activities," coauthor Anisa Kelley, M.D., also from the Northwestern University Feinberg School of Medicine, said in a statement. "Currently, there is only one FDA-approved migraine preventative medication for this age group. Our results are encouraging, showing zonisamide may be another option for reducing migraine attacks."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
2023 Unintentional Fall Death Rate Was 69.9/100,000 in Those Aged 65 and Older
WEDNESDAY, June 18, 2025 -- For adults aged 65 years and older, the unintentional fall death rate was 69.9 per 100,000 population in 2023 and increased with increasing age...
FDA Offers Speedier Approvals to Drug Companies Aligning With 'National Priorities'
WEDNESDAY, June 18, 2025 -- On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an initiative that will...
Waist-to-Height Ratio Predicts Liver Steatosis and Fibrosis
WEDNESDAY, June 18, 2025 -- Waist-to-height ratio (WHtR) outperforms body mass index (BMI) in detecting the risk for liver disease, according to a study published in the July...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.